<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.reuters.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
<channel>
<title>Reuters: Healthcare</title>
<link>http://www.reuters.com</link>
<description>Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks.  Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.</description>
<image>
	<title>Reuters News</title>
	<width>120</width>
	<height>35</height>
	<link>http://www.reuters.com</link>
	<url>http://www.reuters.com/resources_v2/images/reuters125.png</url>
</image>
<language>en-us</language>
<lastBuildDate>Thu, 17 May 2012 12:50:50 -0400</lastBuildDate>
<copyright>All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks or trademarks of the Reuters group of companies around the world. Â© Reuters 2012</copyright>
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.reuters.com/reuters/UShealthcareNews" /><feedburner:info uri="reuters/ushealthcarenews" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item>
		<title>UPDATE 2-Computer Sciences Corp CEO plans $1 bln in cuts</title>


		<description>May 17 (Reuters) - Computer Sciences Corp's new CEO
vowed to turn around his struggling firm as it posted an annual
loss of $4.2 billion, saying he is working hard to lay the
groundwork for a return to profitability.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=p7k60GM9G6w:oMQH6GNHJD4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=p7k60GM9G6w:oMQH6GNHJD4:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=p7k60GM9G6w:oMQH6GNHJD4:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=p7k60GM9G6w:oMQH6GNHJD4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=p7k60GM9G6w:oMQH6GNHJD4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/UShealthcareNews/~4/p7k60GM9G6w" height="1" width="1"/&gt;</description>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/p7k60GM9G6w/csc-idUSL1E8GH2M920120517</link>
        <guid isPermaLink="false">http://www.reuters.com/article/2012/05/17/csc-idUSL1E8GH2M920120517?feedType=RSS&amp;feedName=rbssHealthcareNews</guid>
        <category>rbssHealthcareNews</category>
		<pubDate>Thu, 17 May 2012 12:24:57 -0400</pubDate>
		<feedburner:origLink>http://www.reuters.com/article/2012/05/17/csc-idUSL1E8GH2M920120517?feedType=RSS&amp;feedName=rbssHealthcareNews</feedburner:origLink></item>
<item>
		<title>Study unpicks gene changes behind breast cancer</title>


		<description>LONDON, May 17 (Reuters) - Scientists have mapped the
complete genetic codes of 21 breast cancers and created a
catalogue of the mutations that accumulate in breast cells,
raising hopes that the disease may be able to be spotted earlier
and treated more effectively in future.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=rMuIyWh6Yxs:VCYi6hvOU14:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=rMuIyWh6Yxs:VCYi6hvOU14:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=rMuIyWh6Yxs:VCYi6hvOU14:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=rMuIyWh6Yxs:VCYi6hvOU14:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=rMuIyWh6Yxs:VCYi6hvOU14:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/UShealthcareNews/~4/rMuIyWh6Yxs" height="1" width="1"/&gt;</description>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/rMuIyWh6Yxs/cancer-breast-genetics-idUSL5E8GGI7Z20120517</link>
        <guid isPermaLink="false">http://www.reuters.com/article/2012/05/17/cancer-breast-genetics-idUSL5E8GGI7Z20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</guid>
        <category>rbssHealthcareNews</category>
		<pubDate>Thu, 17 May 2012 12:00:00 -0400</pubDate>
		<feedburner:origLink>http://www.reuters.com/article/2012/05/17/cancer-breast-genetics-idUSL5E8GGI7Z20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</feedburner:origLink></item>
<item>
		<title>UPDATE 3-Agilent to buy Denmark's Dako for $2.2 bln</title>


		<description>May 17 (Reuters) - Agilent Technologies Inc will buy
Danish cancer diagnostics company Dako from Sweden-based private
equity group EQT for $2.2 billion in its biggest ever deal, to
expand into the high-growth medical diagnostics market.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=yW0cDrkD-mg:Fb_ctrji5tU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=yW0cDrkD-mg:Fb_ctrji5tU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=yW0cDrkD-mg:Fb_ctrji5tU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=yW0cDrkD-mg:Fb_ctrji5tU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=yW0cDrkD-mg:Fb_ctrji5tU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/UShealthcareNews/~4/yW0cDrkD-mg" height="1" width="1"/&gt;</description>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/yW0cDrkD-mg/agilent-idUSL4E8GH6IO20120517</link>
        <guid isPermaLink="false">http://www.reuters.com/article/2012/05/17/agilent-idUSL4E8GH6IO20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</guid>
        <category>rbssHealthcareNews</category>
		<pubDate>Thu, 17 May 2012 11:50:06 -0400</pubDate>
		<feedburner:origLink>http://www.reuters.com/article/2012/05/17/agilent-idUSL4E8GH6IO20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</feedburner:origLink></item>
<item>
		<title>Specialty drug costs a major employer worry-survey</title>


		<description>May 17 (Reuters) - Employers want to step up programs to
encourage healthier behavior among their workers and to control
spending on expensive injected specialty medicines, according to
a survey by  pharmacy benefit manager Express Scripts Holding Co
.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=_iRWidNWZN4:XItmNPY045k:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=_iRWidNWZN4:XItmNPY045k:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=_iRWidNWZN4:XItmNPY045k:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=_iRWidNWZN4:XItmNPY045k:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=_iRWidNWZN4:XItmNPY045k:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/UShealthcareNews/~4/_iRWidNWZN4" height="1" width="1"/&gt;</description>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/_iRWidNWZN4/expressscripts-survey-idUSL1E8GGOV020120517</link>
        <guid isPermaLink="false">http://www.reuters.com/article/2012/05/17/expressscripts-survey-idUSL1E8GGOV020120517?feedType=RSS&amp;feedName=rbssHealthcareNews</guid>
        <category>rbssHealthcareNews</category>
		<pubDate>Thu, 17 May 2012 10:59:37 -0400</pubDate>
		<feedburner:origLink>http://www.reuters.com/article/2012/05/17/expressscripts-survey-idUSL1E8GGOV020120517?feedType=RSS&amp;feedName=rbssHealthcareNews</feedburner:origLink></item>
<item>
		<title>Computer Sciences posts loss due to UK contract</title>


		<description>May 17 (Reuters) - Computer Sciences Corp reported a
quarterly loss as it ran into problems implementing a massive
system for managing digital medical records for Britain's
National Health Service.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=xwc4pa26qaU:CQG3gLHy1Js:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=xwc4pa26qaU:CQG3gLHy1Js:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=xwc4pa26qaU:CQG3gLHy1Js:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=xwc4pa26qaU:CQG3gLHy1Js:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=xwc4pa26qaU:CQG3gLHy1Js:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/UShealthcareNews/~4/xwc4pa26qaU" height="1" width="1"/&gt;</description>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/xwc4pa26qaU/csc-idUSL1E8GGNMM20120517</link>
        <guid isPermaLink="false">http://www.reuters.com/article/2012/05/17/csc-idUSL1E8GGNMM20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</guid>
        <category>rbssHealthcareNews</category>
		<pubDate>Thu, 17 May 2012 09:13:43 -0400</pubDate>
		<feedburner:origLink>http://www.reuters.com/article/2012/05/17/csc-idUSL1E8GGNMM20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</feedburner:origLink></item>
<item>
		<title>UPDATE 2-Investors punish TowerJazz over quarterly outlook</title>


		<description>* Q1 revenue up 39 pct to $168 mln, in line with forecast&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=u1-f8Yr7jZA:tRyiS_Jx5U0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=u1-f8Yr7jZA:tRyiS_Jx5U0:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=u1-f8Yr7jZA:tRyiS_Jx5U0:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=u1-f8Yr7jZA:tRyiS_Jx5U0:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=u1-f8Yr7jZA:tRyiS_Jx5U0:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/UShealthcareNews/~4/u1-f8Yr7jZA" height="1" width="1"/&gt;</description>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/u1-f8Yr7jZA/towersemiconductor-results-idUSL4E8GH4Z620120517</link>
        <guid isPermaLink="false">http://www.reuters.com/article/2012/05/17/towersemiconductor-results-idUSL4E8GH4Z620120517?feedType=RSS&amp;feedName=rbssHealthcareNews</guid>
        <category>rbssHealthcareNews</category>
		<pubDate>Thu, 17 May 2012 08:40:22 -0400</pubDate>
		<feedburner:origLink>http://www.reuters.com/article/2012/05/17/towersemiconductor-results-idUSL4E8GH4Z620120517?feedType=RSS&amp;feedName=rbssHealthcareNews</feedburner:origLink></item>
<item>
		<title>RPT-Pfizer drug effective in rare children's cancers</title>


		<description>* Crizotinib eradicated cancer in 7 of 8 lymphoma patients&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=-RbWtTGsQmU:YOYKuNpNMYU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=-RbWtTGsQmU:YOYKuNpNMYU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=-RbWtTGsQmU:YOYKuNpNMYU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=-RbWtTGsQmU:YOYKuNpNMYU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=-RbWtTGsQmU:YOYKuNpNMYU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/UShealthcareNews/~4/-RbWtTGsQmU" height="1" width="1"/&gt;</description>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/-RbWtTGsQmU/cancer-pfizer-children-idUSL1E8GGS6720120517</link>
        <guid isPermaLink="false">http://www.reuters.com/article/2012/05/17/cancer-pfizer-children-idUSL1E8GGS6720120517?feedType=RSS&amp;feedName=rbssHealthcareNews</guid>
        <category>rbssHealthcareNews</category>
		<pubDate>Thu, 17 May 2012 06:59:55 -0400</pubDate>
		<feedburner:origLink>http://www.reuters.com/article/2012/05/17/cancer-pfizer-children-idUSL1E8GGS6720120517?feedType=RSS&amp;feedName=rbssHealthcareNews</feedburner:origLink></item>
<item>
		<title>RPT-Glaxo melanoma drug combo shows promise in small trial</title>


		<description>May 16 (Reuters) - Two drugs being developed by
GlaxoSmithKline Plc - each designed to block different
pathways used by cancer cells - have been shown in a small
clinical trial to curb melanoma with fewer side effects than
current therapies.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=UNfCJ5WSQSY:yY0YA1o__to:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=UNfCJ5WSQSY:yY0YA1o__to:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=UNfCJ5WSQSY:yY0YA1o__to:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=UNfCJ5WSQSY:yY0YA1o__to:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=UNfCJ5WSQSY:yY0YA1o__to:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/UShealthcareNews/~4/UNfCJ5WSQSY" height="1" width="1"/&gt;</description>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/UNfCJ5WSQSY/cancer-glaxo-melanoma-idUSL1E8GGS2C20120517</link>
        <guid isPermaLink="false">http://www.reuters.com/article/2012/05/17/cancer-glaxo-melanoma-idUSL1E8GGS2C20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</guid>
        <category>rbssHealthcareNews</category>
		<pubDate>Thu, 17 May 2012 06:59:54 -0400</pubDate>
		<feedburner:origLink>http://www.reuters.com/article/2012/05/17/cancer-glaxo-melanoma-idUSL1E8GGS2C20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</feedburner:origLink></item>
<item>
		<title>UPDATE 1-Prestige Brands 4th-qtr profit beats Street</title>


		<description>May 17 (Reuters) - Prestige Brands Holdings Inc 
posted an adjusted quarterly profit that beat analysts'
expectations, helped by higher sales of its over-the-counter
brands.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=Qz7fLNGCeBo:r9suuYySFro:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=Qz7fLNGCeBo:r9suuYySFro:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=Qz7fLNGCeBo:r9suuYySFro:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=Qz7fLNGCeBo:r9suuYySFro:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=Qz7fLNGCeBo:r9suuYySFro:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/UShealthcareNews/~4/Qz7fLNGCeBo" height="1" width="1"/&gt;</description>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/Qz7fLNGCeBo/prestigebrands-idUSL4E8GH63R20120517</link>
        <guid isPermaLink="false">http://www.reuters.com/article/2012/05/17/prestigebrands-idUSL4E8GH63R20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</guid>
        <category>rbssHealthcareNews</category>
		<pubDate>Thu, 17 May 2012 06:46:44 -0400</pubDate>
		<feedburner:origLink>http://www.reuters.com/article/2012/05/17/prestigebrands-idUSL4E8GH63R20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</feedburner:origLink></item>
<item>
		<title>STOCKS NEWS THAILAND-Advanced Info Service up on 3G hopes</title>


		<description>Shares in Advanced Info Service Pcl climbed to a 
one-week high amid expectations that the country's biggest
mobile phone operator would win the most spectrum lots of 3G
spectrum licences in an auction scheduled for September or
October.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=g76ZfXi6yLM:a4OFtsEGL30:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=g76ZfXi6yLM:a4OFtsEGL30:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=g76ZfXi6yLM:a4OFtsEGL30:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.reuters.com/~ff/reuters/UShealthcareNews?a=g76ZfXi6yLM:a4OFtsEGL30:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/UShealthcareNews?i=g76ZfXi6yLM:a4OFtsEGL30:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/UShealthcareNews/~4/g76ZfXi6yLM" height="1" width="1"/&gt;</description>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/g76ZfXi6yLM/stocksnews-thailand-idUSL4E8GH5XT20120517</link>
        <guid isPermaLink="false">http://www.reuters.com/article/2012/05/17/stocksnews-thailand-idUSL4E8GH5XT20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</guid>
        <category>rbssHealthcareNews</category>
		<pubDate>Thu, 17 May 2012 04:33:29 -0400</pubDate>
		<feedburner:origLink>http://www.reuters.com/article/2012/05/17/stocksnews-thailand-idUSL4E8GH5XT20120517?feedType=RSS&amp;feedName=rbssHealthcareNews</feedburner:origLink></item>
</channel>
</rss>
